Skip to main content
CYCLOPHARM LIMITED logo

CYCLOPHARM LIMITED — Investor Relations & Filings

Ticker · CYC ISIN · AU000000CYC5 LEI · 9845008C9R4608FB7007 ASX Manufacturing
Open in API
Filings indexed 777 across all filing types
Latest filing 2011-05-25 Governance Information
Country AU Australia
Listing ASX CYC

About CYCLOPHARM LIMITED

https://www.cyclopharm.com.au

Cyclopharm Limited focuses on the development and commercialization of specialized medical imaging technologies. Its primary product, Technegas, is an ultra-fine dispersion of carbon nano-particles labeled with Technetium-99m, utilized for functional lung ventilation imaging. This technology is used to diagnose Pulmonary Embolism by providing high-resolution images via the inhalation of a radioactive aerosol. Technegas is generated on-site using proprietary equipment and is compatible with SPECT and SPECT/CT imaging. The system is engineered to provide diagnostic clarity even in patients with underlying airway diseases. Beyond its primary diagnostic use, the company investigates applications for its technology in managing chronic obstructive pulmonary disease (COPD), asthma, and lung cancer.

Recent filings

Filing Released Lang Actions
New constitution 86 pages 218.7KB
Governance Information Classification · 95% confidence The document is titled 'Constitution of Cyclopharm Limited' and contains detailed sections on the company's internal rules, including appointment and removal of directors, directors' powers, meetings, voting rights, proxies, audit and accounts, and share control. The content is focused on governance structure and company bylaws rather than financial performance or announcements. There is no indication that this is an annual report, audit report, or any financial statement. Instead, it aligns with a governance document outlining the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content support this classification with high confidence.
2011-05-25 English
Initial Director`s Interest Notice 1 page 44.7KB
Board/Management Information Classification · 100% confidence The document is extremely short (112 characters) and contains only a brief statement about the appointment date of a director named Alexander Beard. This matches the description of an announcement of changes in the company's board of directors or senior management. There is no financial data or detailed report content. Therefore, the document fits the category of Board/Management Information (MANG).
2011-05-04 English
Director Appointment/Resignation 2 pages 112.1KB
Board/Management Information Classification · 100% confidence The document is a formal announcement dated 29 April 2011 from Cyclopharm Limited to the Australian Securities Exchange. It announces the appointment of Mr. Alexander (Sandy) Beard as a non-executive director effective immediately. The content focuses on the appointment of a board member and provides background information about the company and its operations. There are no financial statements, earnings data, or detailed management discussion. The document is clearly about a change in the company's board of directors, which fits the category of Board/Management Information (MANG). The document length is 3496 characters, which is consistent with a brief announcement rather than a full report or presentation.
2011-04-28 English
Notice of General Meeting/Proxy Form 24 pages 105.9KB
AGM Information Classification · 100% confidence The document is titled 'Notice of Annual General Meeting and Explanatory Statement' for Cyclopharm Limited, detailing the agenda, resolutions to be voted on, and explanatory notes for the AGM scheduled on 26 May 2011. It includes information on ordinary and special business, such as financial statements receipt, remuneration report adoption, director re-election, share buy-back approval, amendments to the constitution, and proxy voting instructions. The document is a formal notice and explanatory material for the AGM, not the actual annual report or financial statements themselves. It is a typical AGM notice and explanatory statement document used to inform shareholders prior to the meeting and solicit votes on resolutions. Therefore, the correct classification is AGM Information (AGM-R).
2011-04-17 English
Annual Report to shareholders 90 pages 908.3KB
Annual Report Classification · 100% confidence The document is titled 'Cyclopharm Limited Annual Report 2010' and contains detailed sections typical of an annual report, including financial highlights, chairman's letter, managing director's review, directors' report, auditor's independence declaration, corporate governance, comprehensive income statement, financial position, cash flows, changes in equity, notes, director's declaration, independent audit report, and additional information. The content includes full financial data, management discussion, and strategic outlook for the company. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. There is no indication that this is merely an announcement of the report or a certification document. Therefore, this document fits the definition of an Annual Report (10-K). FY 2010
2011-03-24 English
Company Secretary Appointment/Resignation 2 pages 94.5KB
Board/Management Information Classification · 95% confidence The document is a company announcement dated 25 March 2011 regarding the appointment and resignation of the Company Secretary at Cyclopharm Limited. It includes background information about the company and its operations but does not contain financial statements, audit information, or regulatory filings. The primary content is about a change in senior management position (Company Secretary). Therefore, it fits the category of Board/Management Information (MANG). The document length is 3628 characters, which is consistent with a brief announcement rather than a full report.
2011-03-24 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.